HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study "Freshens" Concerns About Chemicals In Baby Products, Campaign Says

This article was originally published in The Rose Sheet

Executive Summary

Research identifying high rates of sensitization to formaldehyde-releasing preservatives (FRPs) among children lends credence to concerns expressed in its "Toxic Tub" report released earlier this year, the Campaign for Safe Cosmetics suggests

You may also be interested in...



TaikiUSA Touts Preservative-Free Mascara With EcoG+ Technology

EcoG+ packaging technology reduces or even eliminates the need for harsh preservatives in eye-area cosmetics and other personal-care formulas, according to TaikiUSA. The “antimicrobial resin” also offers environmental benefits firms can promote to consumers wary of parabens and other strong preservatives.

J&J Singled Out By Safe Cosmetics Campaign For “Toxins” In Baby Care

A coalition of health advocacy organizations led by the Campaign for Safe Cosmetics is asking industry leader Johnson & Johnson to remove alleged toxins from its baby products

“Toxic Tub” Spill Contained Overseas In Time For Class-Action Suit At Home

American personal-care marketers Johnson & Johnson, Procter & Gamble, Kimberly Clark and Limited Brands are among firms named in a class-action lawsuit stemming from a Campaign for Safe Cosmetics' study that caused some children's bath products to be pulled from shelves in China

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016443

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel